投稿についてもっと詳しく Cilcare announces presentation of DIAMANT clinical trial results at ARO 2026, advancing biomarkers for hidden hearing loss in metabolic disorders

Cilcare announces presentation of DIAMANT clinical trial results at ARO 2026, advancing biomarkers for hidden hearing loss in metabolic disorders

Montpellier, France – February 6, 2026 – Cilcare, a biotechnology company specializing in auditory sciences, is pleased to announce the presentation of clinical results from its first observational clinical study,…

続きを読むCilcare announces presentation of DIAMANT clinical trial results at ARO 2026, advancing biomarkers for hidden hearing loss in metabolic disorders
投稿についてもっと詳しく Development of the first inner ear organoids by 3D bioprinting for pharmacological screening in hearing disorders: CILCARE announces strategic agreement with CTIBIOTECH and SATT AxLR

Development of the first inner ear organoids by 3D bioprinting for pharmacological screening in hearing disorders: CILCARE announces strategic agreement with CTIBIOTECH and SATT AxLR

CTIBIOTECH has been selected by SATT AxLR and CILCARE to develop the OrgaEar project, a disruptive innovation in hearing disorders research. Hearing disorders are a growing public health crisis. The…

続きを読むDevelopment of the first inner ear organoids by 3D bioprinting for pharmacological screening in hearing disorders: CILCARE announces strategic agreement with CTIBIOTECH and SATT AxLR
投稿についてもっと詳しく Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders

Cilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders

Cilcare is pleased to announce that its innovative INEAR3D project has been selected by the Companies & Campus initiative, supported by the University of Montpellier and its Pôle Universitaire d’Innovation…

続きを読むCilcare launches a groundbreaking 3D Bioprinting Project with human cells to advance therapies for hearing disorders
投稿についてもっと詳しく Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers

Cilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers

Cilcare takes a major step forward with the launch of SAPHIR, a groundbreaking study on the link between hearing disorders and neurodegenerative diseases. A pioneering observational clinical study conducted in…

続きを読むCilcare launches a new study to explore hearing in patients with early-stage neurodegenerative diseases and identify new auditory biomarkers